Unique ID issued by UMIN | UMIN000010115 |
---|---|
Receipt number | R000011854 |
Scientific Title | The utility of I-FOBT to predict relapsing inflammation in the patients with quiescent ulcerative colitis |
Date of disclosure of the study information | 2013/02/28 |
Last modified on | 2014/08/25 20:49:25 |
The utility of I-FOBT to predict relapsing inflammation in the patients with quiescent ulcerative colitis
Association of I-FOBT with UCCIS in quiescent ulcerative colitis patients
The utility of I-FOBT to predict relapsing inflammation in the patients with quiescent ulcerative colitis
Association of I-FOBT with UCCIS in quiescent ulcerative colitis patients
Japan |
Ulcerative colitis
Medicine in general |
Others
NO
To investigate the association of I-FOBT with UCCIS in quiescent ulcerative colitis patients and to evaluate the utility of I-FOBT to predict relapse as a noninvasive screening examination
Others
The investigation of the efficacy of I-FOBT for the natural course of ulcerative colitis
Association between I-FOBT and UCCIS
relapse rate and time to relapse
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1) Outpatients
2) Adult patients who have been diagnosed as ulcerative colitis according to the diagnostic criteria for ulcerative colitis (draft revised on January 26, 2012)
3) Those who are diagnosed in the clinically remission stage (PGA=0)
4) Patients who were induced remission with SASP, mesalazine, steroid or immunomodulator and are maintained with those drugs
5) Patients who have received adequate information regarding this study and understood thoroughly, and then voluntarily submitted written consent forms upon participation in this study
1) Patients who have received total / subtotal colectomy
2) Patients who have been complicated or have history with malignant tumor
3) Patients who were induced or maintained remission with biologics
4) Patients who needed dose-increase or addition of drug for maintenance of remission during study period
5) Patients who are pregnant or possibly pregnant
6) Other patients whom investigators and subinvestigators considered inappropriate to participate in this study
60
1st name | |
Middle name | |
Last name | Yuji Naito |
Kyoto Prefectural University of Medicine
Molecular Gastroenterology and Hepatology
465 Kajii-cho, Hirokoji, Kamigyo-ku, Kyoto, Japan
075-251-5519
ynaito@koto.kpu-m.ac.jp
1st name | |
Middle name | |
Last name | Tomohisa Takagi |
Kyoto Prefectural University of Medicine
Molecular Gastroenterology and Hepatology
465 Kajii-cho, Hirokoji, Kamigyo-ku, Kyoto, Japan
075-251-5519
takatomo@koto.kpu-m.ac.jp
Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine
None
Self funding
NO
2013 | Year | 02 | Month | 28 | Day |
Unpublished
Completed
2013 | Year | 01 | Month | 28 | Day |
2013 | Year | 02 | Month | 28 | Day |
2014 | Year | 08 | Month | 01 | Day |
2014 | Year | 08 | Month | 31 | Day |
2014 | Year | 12 | Month | 31 | Day |
2015 | Year | 03 | Month | 31 | Day |
To investigate the relationship between I-FOBT and endoscopic findings of the patients with ulcerative colitis in remission phase prospectively. The medication will be changed to 2g/day of 5-ASA.
2013 | Year | 02 | Month | 25 | Day |
2014 | Year | 08 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011854
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |